Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01973699 · ClinicalTrials.gov registry record · NA
Visualization in Shoulder Arthroscopy With and Without Epinephrine
A NA study, sponsored by St. Luke's Hospital, Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT01973699: Completed NA study, sponsored by St. Luke's Hospital, Pennsylvania.
NCT01973699 is a NA study that has completed, run by St. Luke's Hospital, Pennsylvania. The registered enrollment target is 83 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01973699, a NA study, has completed, sponsored by St. Luke's Hospital, Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
Adequate visualization during shoulder arthroscopy is of great importance for the procedure to be efficiently and effectively performed. The use of dilute epinephrine in irrigation fluid has been historically utilized to help with visualization. Given the potential safety issues documented in the literature related to epinephrine use, as well as the significant improvements in technique and instrumentation over the last decade, the need for this additive should be reexamined. The objective of the current study was to compare surgeon determined visualization in shoulder arthroscopy using irrigation fluid with and without epinephrine.
Primary Outcome
surgeon determined visualization during shoulder arthroscopy as judged by a VAS
Interventions
- OTHER visualization in shoulder arthroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-08 |
| Phase | NA |
What the finished NCT01973699 record still lists
NCT01973699 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which visualization in shoulder arthroscopy is the first listed.
NCT01973699 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01973699 about?
NCT01973699 is a clinical study titled "Visualization in Shoulder Arthroscopy With and Without Epinephrine". Adequate visualization during shoulder arthroscopy is of great importance for the procedure to be efficiently and effectively performed. The use of dilute epinephrine in irrigation fluid has been historically utilized to help with visualization. Given the potential safety issues documented in the li...
What is the current status of trial NCT01973699?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2012-11. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01973699?
The interventions under investigation include: visualization in shoulder arthroscopy (OTHER).
Who is sponsoring clinical trial NCT01973699?
This trial is sponsored by St. Luke's Hospital, Pennsylvania, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01973699's enrollment target sits among peer trials
83 990th of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia